What is Reverse Genetics?

NewsGuard 100/100 Score

Reverse genetics enables researchers to understand gene function by observing changes to phenotypes of cells and organisms that are created with modifications to their genomes. Reverse genetics also plays a crucial role in the development of highly specific live attenuated versions of vaccines against specific viruses.

GeneticsImage Credit: sokolova_sv/Shutterstock.com

What is reverse genetics?

Reverse genetics is an experimental molecular genetics technique that enables researchers to elucidate gene function by examining changes to phenotypes (of cells or organisms) caused by genetically engineering specific nucleic acid sequences (within DNA or RNA).

In forward genetics, the genetic bases responsible for a particular phenotype are established – i.e. by examining naturally occurring mutations or mutations induced by radiation or chemicals. Mutant individuals (cells or organisms) are isolated based on their phenotype, and their genome is mapped to confirm phenotype to genetics.

Altering the genetic sequence in reverse genetics typically involves directed deletions and point mutations (site-directed mutagenesis) to create null alleles (non-functional); such as gene knockouts.

In mice, this can create an organism with a specific gene ‘knocked-out’ and the phenotype of the animal can then be observed. Knockouts lead to permanent loss-of-function genetic organisms (or cells) from birth.

Other techniques include genetic engineering to substitute DNA sequences for a one-for-one substitution – called a gene knock-in – which is then inserted into a specific locus. Both knockouts and knock-ins, in addition to other forms of highly targeted and specific genetic engineering, can be achieved by CRISPR-Cas9 – whereby a cells’ genome can be cut at a specific location allowing genes to either be removed or new engineered sequences to be inserted instead.

Gene knockdowns – an incomplete form of genetic knockout – can be achieved by gene silencing by the use of RNA interference (RNAi), typically by siRNA or Vivo-Morpholinos. Genetic knockdowns are typically temporary whereas genetic knockouts are permanent.

RNAi is especially useful to knockdown a gene without actually having to change the genetic sequence itself and maybe a useful therapeutic tool in the treatment of cancers, neurological diseases, and viral infections. RNAi is also an effective reverse genetics tool in creating a loss-of-function phenotype of a gene at any stage.

Conversely, overexpression of a normal gene of interest can also be engineered or overexpressing genetically engineered mutant forms of a gene. Overexpressing a mutant allele (whilst having one functional allele) may result in a dominant-negative interaction whereby the mutant allele produced a non-functional protein ‘outcompeting’ the functional protein.

Therapeutic applications of reverse genetics

So far, this article has discussed how reverse genetics can be used in the creation of genetically altered animals (or cells) to study the effect of specific genetic mutations (insertions, deletions; knockouts, knock-ins) on the phenotype.

However, reverse genetics has many important therapeutic applications – especially in the engineering of vaccines against viruses and/or the reconstruction of a viral genome.

In vaccine development, reverse genetics can be used to create viral strains that have reduced pathogenicity but still be able to be robustly recognized by the immune system to lead to the creation of antibodies against the virus. Doing so allows for specific alterations to the viral genome creating more advanced vaccinations (live attenuated vaccines) compared to the traditional heat-mediated inactivated vaccines.

Live attenuated vaccines have higher immunogenicity compared to inactivated vaccines due to the virus being ‘live’, however, this may present a problem in immunocompromised (immunodeficient) individuals.

Live attenuated vaccines are created by using reverse genetic tools to combine genes from current (novel) with previously altered (attenuated) viruses belonging to the same generic strain. However, as these live viruses are attenuated, they cannot replicate to the same extent as live unattenuated viruses, such that they are no longer able to sufficiently infect the host, but enough that immunity can develop.

The most successful example of a live attenuated vaccine is that of the influenza vaccine, which can provide up to 90% protection in adults under 65 years of age, and up to 40% of adults over 65. The influenza A virus has 8 RNA segments. In the live attenuated vaccine, a combination of 6 attenuated segments combined with 2 normal (WT) segments – engineered into plasmids – creating a live attenuated vaccine.

Concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, many independent groups have successfully used reverse genetics to reconstruct its full genome and to assess specific sequences that help it to bind to its receptor (ACE2) as well as other key elements of the virus. Doing so provides a great boost in the hope to create a live attenuated vaccine for SARS-CoV-2, however, only time will tell if is effective in the prevention against COVID-19.

In summary, reverse genetics plays a crucial role in the development of genetically engineered cells and organisms that enable scientists to understand gene function by observing changes to their phenotypes. Examples include “knockout animals” or the use of CRISPR-Cas9.

Therapeutically, reverse genetics is used extensively to genetically modify viral genomes to alter their pathogenicity in the development of live attenuated vaccines, which have higher immunogenicity compared to traditional inactivated vaccines.

COVID-19 VaccineImage Credit: solarseven/Shutterstock.com


Further Reading

Last Updated: Jul 21, 2023

Dr. Osman Shabir

Written by

Dr. Osman Shabir

Osman is a Postdoctoral Research Associate at the University of Sheffield studying the impact of cardiovascular disease (atherosclerosis) on neurovascular function in vascular dementia and Alzheimer's disease using pre-clinical models and neuroimaging techniques. He is based in the Department of Infection, Immunity & Cardiovascular Disease in the Faculty of Medicine at Sheffield.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Shabir, Osman. (2023, July 21). What is Reverse Genetics?. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/health/What-is-Reverse-Genetics.aspx.

  • MLA

    Shabir, Osman. "What is Reverse Genetics?". News-Medical. 18 April 2024. <https://www.news-medical.net/health/What-is-Reverse-Genetics.aspx>.

  • Chicago

    Shabir, Osman. "What is Reverse Genetics?". News-Medical. https://www.news-medical.net/health/What-is-Reverse-Genetics.aspx. (accessed April 18, 2024).

  • Harvard

    Shabir, Osman. 2023. What is Reverse Genetics?. News-Medical, viewed 18 April 2024, https://www.news-medical.net/health/What-is-Reverse-Genetics.aspx.


  1. Jon Moulton Jon Moulton United States says:

    The term RNAi is typically used to describe processes mediated by RISC.  Morpholino oligos do not use RISC for their activity, so they are commonly described as antisense oligos but not as RNAi.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.